Shares of Calithera Biosciences, Inc. (NASDAQ:CALA – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. Calithera Biosciences shares last traded at $0.00, with a volume of 473 shares.
Analyst Upgrades and Downgrades
Separately, StockNews.com assumed coverage on Calithera Biosciences in a research report on Thursday. They set a “hold” rating on the stock.
Read Our Latest Report on CALA
Calithera Biosciences Stock Performance
About Calithera Biosciences
Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.
See Also
- Five stocks we like better than Calithera Biosciences
- The Significance of Brokerage Rankings in Stock Selection
- Top 3 Reasons to Invest in This Bond ETF for Stability and Growth
- What is the Nikkei 225 index?
- 2 Drone Stocks Surging from Increased Media Attention
- Compound Interest and Why It Matters When Investing
- Ciena Rebounds: AI and Strong Guidance Drive Post-Earnings Surge
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
